Lung cancer screening: is France delaying too much?

After breast, colorectal and cervical cancers, will we see the emergence of organized lung cancer screening in France? Scientifically, the benefit is no longer in doubt: it makes it possible to reduce the mortality of this particularly tricky cancer, often diagnosed at a stage too late to hope for a cure. So for more than ten years we have been talking about offering it to all people at risk. And yet, it is still not in place. For what ?

Cancer diagnosed very late

Lung cancer is the 3rd most common cancer in France (nearly 53,000 new cases per year), but also the deadliest of all (30,400 deaths). It is a cancer with a poor prognosis: the 5-year survival rate is barely 20%, despite major progress in recent years. A figure that could drastically change if we detected it earlier: « Patients whose cancer is diagnosed at a very localized stage…